Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Obesity Research & Clinical Practice|June 13, 2017
DP1 receptor agonist, BW245C inhibits diet-induced obesity in ApoE<sup>-/-</sup> miceSunil Kumar, Thomas Palaia, Christopher Hall, et al.
The Journal of Biological Chemistry|April 10, 2003
Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cellsLouis Ragolia, Thomas Palaia, Enesa Paric, et al.
American Journal of Physiology. Cell Physiology|October 22, 2002
Elevated L-PGDS activity contributes to PMA-induced apoptosis concomitant with downregulation of PI3-KLouis Ragolia, Thomas Palaia, Enesa Paric, et al.
Seminars in Nephrology|September 12, 2002
Contribution of prostaglandin D2 synthase to progression of renal failure and dialysis dementiaJohn K Maesaka, Thomas Palaia, Steven Fishbane, et al.
Prostaglandins & Other Lipid Mediators|May 13, 2015
Role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) and its metabolite, prostaglandin D2, in preterm birthSunil Kumar, Thomas Palaia, Christopher E Hall, et al.
Biochemistry and Biophysics Reports|November 11, 2017
Lipocalin-type prostaglandin D<sub>2</sub> synthase reduces glucagon secretion in alpha TC-1 clone 6 cells via the DP1 receptorDavid Davani, Sunil Kumar, Thomas Palaia, et al.
American Journal of Physiology. Cell Physiology|July 9, 2004
Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diabetic Goto-Kakizaki ratsLouis Ragolia, Thomas Palaia, Tara B Koutrouby, et al.
Lung Cancer (Amsterdam, Netherlands)|February 11, 2010
Diminished lipocalin-type prostaglandin D(2) synthase expression in human lung tumorsLouis Ragolia, Thomas Palaia, Christopher E Hall, et al.
Pageof 6